JP2008514203A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008514203A5 JP2008514203A5 JP2007533758A JP2007533758A JP2008514203A5 JP 2008514203 A5 JP2008514203 A5 JP 2008514203A5 JP 2007533758 A JP2007533758 A JP 2007533758A JP 2007533758 A JP2007533758 A JP 2007533758A JP 2008514203 A5 JP2008514203 A5 JP 2008514203A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nucleic acid
- acid molecule
- filovirus
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61388304P | 2004-09-27 | 2004-09-27 | |
| US60/613,883 | 2004-09-27 | ||
| US67760605P | 2005-05-03 | 2005-05-03 | |
| US60/677,606 | 2005-05-03 | ||
| US67976705P | 2005-05-10 | 2005-05-10 | |
| US60/679,767 | 2005-05-10 | ||
| US70169405P | 2005-07-22 | 2005-07-22 | |
| US60/701,694 | 2005-07-22 | ||
| US71587405P | 2005-09-09 | 2005-09-09 | |
| US60/715,874 | 2005-09-09 | ||
| PCT/US2005/034798 WO2006037038A1 (en) | 2004-09-27 | 2005-09-27 | Optimized vaccines to provide protection against ebola and other viruses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008514203A JP2008514203A (ja) | 2008-05-08 |
| JP2008514203A5 true JP2008514203A5 (cg-RX-API-DMAC7.html) | 2008-11-13 |
| JP5046941B2 JP5046941B2 (ja) | 2012-10-10 |
Family
ID=35695786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007533758A Expired - Lifetime JP5046941B2 (ja) | 2004-09-27 | 2005-09-27 | エボラ及び他のウイルスに対する防御に最適化されたワクチン |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8101739B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1797113B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5046941B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005289439B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2581840C (cg-RX-API-DMAC7.html) |
| IL (1) | IL182225A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006037038A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005023170A1 (de) | 2005-05-19 | 2006-11-23 | Curevac Gmbh | Optimierte Formulierung für mRNA |
| US7947286B2 (en) | 2005-10-07 | 2011-05-24 | Panthera Biopharma Llc | Drosophila cell lines producing recombinant secretable filovirus surface glycoproteins lacking the membrane spanning domain |
| JP5670330B2 (ja) | 2008-08-07 | 2015-02-18 | ハー マジェスティ ザ クイーン イン ライト オブ カナダ アズ リプリゼンテド バイ ザ ミニスター オブ ヘルスHER MAJESTY THE QUEEN IN RIGHTOF CANADA as represented by THE MINISTER OF HEALTH | 最適化したプロモーター配列 |
| WO2011130627A2 (en) | 2010-04-16 | 2011-10-20 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Chimpanzee adenoviral vector-based filovirus vaccines |
| KR101879892B1 (ko) * | 2010-12-14 | 2018-08-17 | 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카 에즈 레프리젠티드 바이 더 세크러테리 오브 더 디파트먼트 오브 헬스 앤드 휴먼 서비시즈 | 아데노바이러스 혈청형 26 및 혈청형 35 필로바일러스 백신 |
| FI2764565T3 (fi) | 2011-10-05 | 2023-04-24 | Oned Mat Inc | Piin nanorakenteen aktiivimateriaaleja litiumioniakkuihin ja niihin liittyviä prosesseja, koostumuksia, komponentteja ja laitteita |
| KR20220012403A (ko) * | 2012-04-12 | 2022-02-03 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | 필로바이러스 공통 항원, 이로부터 제조된 핵산 구조체 및 백신, 및 이를 사용하는 방법 |
| RU2019107976A (ru) | 2013-02-21 | 2019-08-23 | Тёрнстоун Лимитед Партнершип | Композиция вакцины |
| CA2952741A1 (en) | 2014-06-26 | 2015-12-30 | Janssen Vaccines & Prevention B.V. | Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau |
| ZA201608812B (en) | 2014-06-26 | 2019-08-28 | Janssen Vaccines & Prevention Bv | Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau |
| CA2959105C (en) * | 2014-09-03 | 2023-10-17 | Bavarian Nordic A/S | Recombinant modified vaccinia virus ankara (mva) filovirus vaccine |
| KR20190062617A (ko) | 2014-09-03 | 2019-06-05 | 버베리안 노딕 에이/에스 | 면역 반응을 증대시키기 위한 방법 및 조성물 |
| AU2015311852B2 (en) | 2014-09-03 | 2018-12-13 | Bavarian Nordic A/S | Methods and compositions for inducing protective immunity against filovirus infection |
| CA2962849A1 (en) * | 2014-12-16 | 2016-06-23 | Curevac Ag | Ebolavirus and marburgvirus vaccines |
| GB201502209D0 (en) | 2015-02-10 | 2015-03-25 | Sec Dep For Health The And Chancellor Masters And Scholars Of The University Of Oxford The And Micro | Filovirus therapy |
| US10479825B2 (en) | 2015-02-25 | 2019-11-19 | Vanderbilt University | Antibody-mediated neutralization of Marburg virus |
| WO2017172622A1 (en) * | 2016-03-28 | 2017-10-05 | Integrated Biotherapeutics, Inc. | Pan filovirus vaccine compositions and methods of making |
| EP3484505A1 (en) | 2016-07-15 | 2019-05-22 | Janssen Vaccines & Prevention B.V. | Methods and compositions for inducing protective immunity against a marburg virus infection |
| US10925956B2 (en) | 2016-07-15 | 2021-02-23 | Janssen Vaccines & Prevention B.V. | Methods and compositions for inducing protective immunity against a marburg virus infection |
| WO2018185732A1 (en) | 2017-04-06 | 2018-10-11 | Janssen Vaccines & Prevention B.V. | Mva-bn and ad26.zebov or ad26.filo prime-boost regimen |
| EP3836961A1 (en) * | 2018-08-13 | 2021-06-23 | Janssen Vaccines & Prevention B.V. | Stabilized filovirus glycoprotein trimers |
| WO2022226060A1 (en) * | 2021-04-21 | 2022-10-27 | Vanderbilt University | Antibody cocktail for treatment of ebolavirus infections |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4631211A (en) | 1985-03-25 | 1986-12-23 | Scripps Clinic & Research Foundation | Means for sequential solid phase organic synthesis and methods using the same |
| WO1999032147A1 (en) * | 1997-12-23 | 1999-07-01 | The Regents Of The University Of Michigan | Immunization for ebola virus infection |
| CA2462455C (en) * | 2001-10-01 | 2012-07-17 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Development of a preventive vaccine for filovirus infection in primates |
| AU2003232004A1 (en) * | 2002-04-30 | 2003-11-17 | The Trustees Of The University Of Pennsylvania | Chimeric ebola virus envelopes and uses therefor |
-
2005
- 2005-09-27 WO PCT/US2005/034798 patent/WO2006037038A1/en not_active Ceased
- 2005-09-27 JP JP2007533758A patent/JP5046941B2/ja not_active Expired - Lifetime
- 2005-09-27 CA CA2581840A patent/CA2581840C/en not_active Expired - Lifetime
- 2005-09-27 AU AU2005289439A patent/AU2005289439B2/en not_active Expired
- 2005-09-27 EP EP05813769.6A patent/EP1797113B1/en not_active Expired - Lifetime
- 2005-09-27 US US11/662,869 patent/US8101739B2/en active Active
-
2007
- 2007-03-27 IL IL182225A patent/IL182225A/en active IP Right Grant
-
2012
- 2012-01-13 US US13/349,917 patent/US9012618B2/en not_active Expired - Lifetime